{"id":"sodium-chloride-24-nacl-0-9","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypernatremia (with excessive or prolonged use)"},{"rate":null,"effect":"Fluid overload/pulmonary edema (in susceptible patients)"},{"rate":null,"effect":"Hyperchloremic acidosis (with large volume infusion)"},{"rate":null,"effect":"Local irritation at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This isotonic saline solution contains sodium and chloride ions in physiological concentrations (0.9% w/v), matching the osmolarity of blood plasma. It is used intravenously or topically to replace lost fluids, maintain hydration, and preserve electrolyte homeostasis without causing cellular osmotic stress. The solution serves as a fundamental vehicle for drug delivery and fluid resuscitation in clinical settings.","oneSentence":"Sodium chloride 0.9% solution restores and maintains electrolyte balance and fluid volume in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:28.880Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration"},{"name":"Vehicle for intravenous drug administration"},{"name":"Wound irrigation and topical cleansing"},{"name":"Maintenance of fluid balance perioperatively"}]},"trialDetails":[{"nctId":"NCT05844657","phase":"","title":"Comprehensive Evaluation in Patients With Meniere's Disease","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2023-05-15","conditions":"Meniere Disease, Psychosocial Problem, Physical Disability","enrollment":34},{"nctId":"NCT02628444","phase":"PHASE2","title":"Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2016-05-02","conditions":"Dengue Fever, Dengue Hemorrhagic Fever","enrollment":1050},{"nctId":"NCT03527355","phase":"PHASE2","title":"Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine","status":"COMPLETED","sponsor":"International Vaccine Institute","startDate":"2018-04-18","conditions":"Typhoid","enrollment":285}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["saline"],"phase":"marketed","status":"active","brandName":"Sodium Chloride, (24)NaCl 0,9%","genericName":"Sodium Chloride, (24)NaCl 0,9%","companyName":"University of Oulu","companyId":"university-of-oulu","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium chloride 0.9% solution restores and maintains electrolyte balance and fluid volume in the body. Used for Fluid and electrolyte replacement in dehydration, Vehicle for intravenous drug administration, Wound irrigation and topical cleansing.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}